NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Earnings Dates, Reports, Calls

Crinetics Pharmaceuticals earnings were -$298.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CRNX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$80.6M, up 4.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRNX reported annual earnings of -$298.4M, with 39.1% growth. The next CRNX earnings date is May 7, 2025.

CRNX earnings history

Current Revenue
$1.0M
Current Earnings
-$298.4M
Current Profit Margin
-28,720.7%

CRNX Return on Equity

Current Company
-30.9%
Current Industry
-2%
Current Market
34.1%
CRNX's Return on Equity (-30.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CRNX undefined

Current Company
-27.9%
Current Industry
-0.4%
CRNX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRNX announces earnings.

CRNX undefined

Current Company
-21.7%
Current Industry
5.9%
CRNX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRNX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRNX-$292.58M-$298.41MN/A-$3.69
PTGX$282.30M$275.19MN/A$4.47
SWTX-$252.88M-$258.13MN/A-$3.48
SRRK-$239.13M-$246.29MN/A-$2.47
CPRX$254.32M$163.89M+34.80%$1.38

CRNX earnings dates

Next earnings date
May 7, 2025

Crinetics Pharmaceuticals Earnings Reports & History FAQ

What were Crinetics Pharmaceuticals's earnings last quarter?

On CRNX's earnings call on Invalid Date, Crinetics Pharmaceuticals (NASDAQ: CRNX) reported Q4 2024 earnings per share (EPS) of -$0.87, up 1.14% year over year. Total CRNX earnings for the quarter were -$80.60 million. In the same quarter last year, Crinetics Pharmaceuticals's earnings per share (EPS) was -$0.88.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.

When does Crinetics Pharmaceuticals report earnings?

The next CRNX earnings date is Invalid Date. Add CRNX to your watchlist to be reminded of Crinetics Pharmaceuticals's next earnings date.

What was CRNX's earnings growth in the past year?

As of Crinetics Pharmaceuticals's earnings date in Invalid Date, Crinetics Pharmaceuticals's earnings has grown year over year. CRNX earnings in the past year totalled -$298.41 million.

Is Crinetics Pharmaceuticals profitable or losing money?

As of the last Crinetics Pharmaceuticals earnings report, Crinetics Pharmaceuticals is currently losing money. Crinetics Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$298.41 million, a 39.1% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.